🇺🇸 FDA
Pipeline program

LB1901

LB1901-TCL-1001

Phase 1 mab active

Quick answer

LB1901 for T-Cell Lymphoma is a Phase 1 program (mab) at Legend Biotech Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
Legend Biotech Corp
Indication
T-Cell Lymphoma
Phase
Phase 1
Modality
mab
Status
active

Clinical trials